- Symbol
- BNTX
- Segment MIC
- XNGS
- ISIN
- US09075V1026
- Trading currency
- USD
XNGS:BNTX — listed on NASDAQ GLOBAL SELECT MARKET
BioNTech SE develops immunotherapies and mRNA vaccines aimed at improving global health. The company focuses on oncology, offering a portfolio that includes mRNA cancer immunotherapies, immunomodulators, and targeted therapies. BioNTech also works on mRNA vaccine programs for infectious diseases, leveraging the technology used in its COVID-19 vaccine. Its research and development efforts are directed towards harnessing the immune system to combat cancer, infectious diseases, and other serious conditions.